← Back to Search

Disclosing Recovery: A Decision Aid and Toolkit for Opioid Use Disorder

N/A
Waitlist Available
Research Sponsored by University of Delaware
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up second study appointment out of two. second appointment took place approximately one month after first study appointment.
Awards & highlights

Study Summary

This study is evaluating whether a brief intervention can help people decide whether to disclose their recovery to others.

Eligible Conditions
  • Opioid Use Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~second study appointment out of two. second appointment took place approximately one month after first study appointment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and second study appointment out of two. second appointment took place approximately one month after first study appointment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Acceptability of Intervention
Decision Making Quality
Feasibility of Intervention
Secondary outcome measures
Commitment to Sobriety
Enacted Stigma
Social Support

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Disclosure Intervention ArmExperimental Treatment1 Intervention
Participants will be guided through a workbook and accompanying worksheet designed to help them: (1) decide whether or not they want to share information about their substance use with others, and (2) build skills for disclosing (e.g., planning what to say). Importantly, the intervention is not designed to encourage participants to disclose or not disclose, but rather to help participants decide whether they want to disclose based on their own goals and values.
Group II: Control ArmActive Control1 Intervention
Participants will be able to choose from several guided meditations to promote mindfulness.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Disclosing Recovery: A Decision Aid and Toolkit
2021
N/A
~50

Find a Location

Who is running the clinical trial?

Massachusetts General HospitalOTHER
2,932 Previous Clinical Trials
13,198,445 Total Patients Enrolled
Harvard School of Public Health (HSPH)OTHER
272 Previous Clinical Trials
16,304,975 Total Patients Enrolled
University of DelawareLead Sponsor
154 Previous Clinical Trials
25,161 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Disclosure Intervention for People in Recovery From Opioid Use Disorder
Valerie Earnshaw 2021. "Disclosure Intervention for People in Recovery From Opioid Use Disorder". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04836247.
~14 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top